Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2026027114-A1 · Jan 29, 2026 · US
This page is not indexed by search engines while we improve data quality.
Sumitomo Pharma Co Ltd — Physics
Sumitomo Pharma Co Ltd holds 40 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Sumitomo Pharma Co Ltd |
| Technology | Physics |
| Patents in slice | 40 |
| Recent patents in slice | 32 |
| First year | 2022 |
| Last year | 2026 |
Representative patents
Notable publications linking Sumitomo Pharma Co Ltd to Physics.
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2026027114-A1 · Jan 29, 2026 · US
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2026027114-A1 · Jan 29, 2026 · US
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2025295663-A1 · Sep 25, 2025 · US
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2025295663-A1 · Sep 25, 2025 · US
Recent filings
Latest patents from Sumitomo Pharma Co Ltd in Physics.
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2026027114-A1 · Jan 29, 2026 · US
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2026027114-A1 · Jan 29, 2026 · US
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2026027114-A1 · Jan 29, 2026 · US
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2025295663-A1 · Sep 25, 2025 · US
Medicament for treating cancer comprising optically active azabicyclo ring derivative
US-2025295663-A1 · Sep 25, 2025 · US
Related pages
Navigate to parent entity pages.